N,1,4,4-tetramethyl-8-(4-(4-methylpiperazin-1-yl)phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]Quinazoline-3-carboxamide

CAS: 802539-81-7

Ref. 3D-FT40655

Información del producto

• Nombre: N,1,4,4-tetramethyl-8-(4-(4-methylpiperazin-1-yl)phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]Quinazoline-3-carboxamide
• CAS: 802539-81-7

Descripción

Palbociclib is a drug that inhibits the activity of the cyclin-dependent kinase inhibitors (CDKIs) CDK4 and CDK6. It prevents their phosphorylation, which in turn prevents cells from progressing through the cell cycle. Palbociclib has been shown to be effective against a number of cancers including brain cancer, breast cancer, and ovarian cancer. Palbociclib is not active against non-malignant cells or cells that have already progressed through the cell cycle, such as thymoma cells. The LC-MS/MS method can be used to measure palbociclib levels in plasma and serum samples.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 460.57 g/mol
• Fórmula: C₂₅H₃₂N₈O
• Pureza: Min. 95%
• InChI: InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)
• Clave InChI: InChIKey=RXZMYLDMFYNEIM-UHFFFAOYSA-N
• SMILES: CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2